Christiane Pendarvis - 13 Mar 2026 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role
Director
Signature
/s/ Kimberly Mather, Attorney-in-Fact for Christiane Pendarvis
Issuer symbol
HIMS
Transactions as of
13 Mar 2026
Net transactions value
$0
Form type
4
Filing time
17 Mar 2026, 16:29:28 UTC
Previous filing
08 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pendarvis Christiane Director 2269 CHESTNUT ST., #523, SAN FRANCISCO /s/ Kimberly Mather, Attorney-in-Fact for Christiane Pendarvis 17 Mar 2026 0001965920

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Options Exercise +15,211 +42% 51,774 13 Mar 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIMS Restricted Stock Unit Options Exercise -15,211 -100% $0.000000* 0 13 Mar 2026 Class A Common Stock 15,211 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU.
F2 The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 3-year period, with : (i) 1/3 of the RSUs vesting on March 15, 2024, (ii) 1/3 of the RSUs vesting on March 15, 2025, and (iii) 1/3 of the RSUs vesting on March 15, 2026.